Trinity Biotech (TRIB) EBIT (QoQ) (2009 - 2024)
Trinity Biotech (TRIB) EBIT (QoQ) (2009 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Trinity Biotech | 93,750.00 | -5.04 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -350.08% |
| Sep 30, 2024 | 36.87% |
| Jun 30, 2024 | -33.25% |
| Mar 31, 2024 | 19.53% |
| Dec 31, 2023 | 16.02% |
| Sep 30, 2023 | 69.70% |
| Jun 30, 2023 | -278.97% |
| Mar 31, 2023 | 51.96% |
| Dec 31, 2022 | -0.32% |
| Sep 30, 2022 | -339.51% |
| Jun 30, 2022 | -52.14% |
| Mar 31, 2022 | -315.99% |
| Dec 31, 2021 | -79.66% |
| Sep 30, 2021 | 1,169.72% |
| Jun 30, 2021 | -92.92% |
| Mar 31, 2021 | -66.05% |
| Dec 31, 2020 | -0.21% |
| Sep 30, 2020 | 1,713.37% |
| Jun 30, 2020 | -70.41% |
| Mar 31, 2020 | 17.24% |